Abstract
Non-small cell lung cancer (NSCLC) driven by activating mutations in epidermal growth factor receptor (EGFR) constitutes up to 10% of NSCLC cases. Acc......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
